Company Filing History:
Years Active: 2022
Title: Guangwei Ren - Innovator in KRAS Inhibitor Research
Introduction
Guangwei Ren is an inventor based in Suzhou, China. He is known for his work in the field of pharmaceutical research, particularly focusing on KRAS inhibitors. His innovative approach aims to address diseases associated with KRAS mutations.
Latest Patent Applications
Guangwei Ren has submitted a patent application titled "KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF." This application discloses KRAS inhibitor compounds characterized by specific structural formulas. The application also details pharmaceutical compositions and methods for inhibiting, treating, and preventing KRAS mutation-associated diseases, disorders, and conditions.
Conclusion
Guangwei Ren's contributions to the field of pharmaceutical research highlight the importance of innovation in developing treatments for complex diseases. His ongoing work in KRAS inhibitors represents a significant step forward in medical science.